EchoIQ Ltd's stock soared 6.29% during intraday trading on Tuesday, reflecting strong investor interest in the artificial intelligence diagnostics company.
The surge follows the announcement that the company's Echosolv artificial intelligence diagnostics tool has been deployed into the Mount Sinai Health System, marking a significant adoption by a major healthcare institution.
Additionally, the company was recently added to the S&P/ASX All Ordinaries Index and is forecasted for rapid revenue growth of 121.3% annually, outpacing the Australian market, with expectations of becoming profitable within three years.